+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurothrombectomy Devices Market by Device Type, Procedure Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Neurothrombectomy Devices Market by Device Type, Procedure Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Neurothrombectomy Devices Market by Device Type, Procedure Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612796
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neurothrombectomy Devices Market grew from USD 875.00 million in 2024 to USD 992.09 million in 2025. It is expected to continue growing at a CAGR of 12.76%, reaching USD 1.79 billion by 2030.

Understanding the Neurothrombectomy Devices Market Evolution

Neurothrombectomy devices have emerged as a critical component in the management of acute ischemic stroke, offering minimally invasive options for clot removal within the cerebral vasculature. Over the past decade, rapid advancements in device design and procedural techniques have transformed the standard of care, shifting the paradigm from systemic thrombolysis to targeted mechanical intervention. The introduction of aspiration catheters and stent retrievers has significantly improved recanalization rates and functional outcomes, reducing long-term disability for many patients.

The market growth has been underpinned by robust clinical evidence demonstrating the superiority of mechanical thrombectomy over pharmacologic approaches, leading to updated treatment guidelines and expanded patient eligibility. At the same time, procedural refinements and imaging enhancements have broadened the therapeutic window, enabling interventions in more complex occlusions. As the field moves forward, integration of real-time analytics and augmented reality navigation promises further precision and safety, setting the stage for the next wave of innovation in neurovascular care.

Emerging Innovations Redefining Stroke Intervention Strategies

Recent years have seen transformative shifts redefining how stroke centers approach mechanical clot removal. Technological innovation has ushered in next-generation devices that combine aspiration capability with stent retriever precision, enabling clinicians to tailor interventions based on clot morphology and vessel anatomy. At the same time, digital platforms for remote image sharing and teleproctoring have accelerated knowledge transfer, allowing high-volume stroke centers to support community hospitals in real time.

Regulatory pathways have also evolved, with accelerated review processes for breakthrough-designated devices reducing time to market. Concurrently, health systems have increasingly embraced integrated care models that align emergency medical services, interventional radiology teams, and post-procedure rehabilitation within coordinated networks. These structural changes have led to faster door-to-reperfusion times and a growing emphasis on patient-centric outcomes, such as quality-adjusted life years, rather than solely procedural metrics.

Assessing 2025 United States Tariff Effects on Trade Dynamics

The introduction of new tariffs on neurothrombectomy devices in 2025 has created a complex dynamic in U.S. trade and procurement strategies. Increased duties on imported components have driven device developers to reassess their manufacturing footprints, with several shifting assembly operations back to domestic facilities to mitigate cost pressures. At the same time, hospitals and surgical centers are negotiating new pricing contracts, seeking volume-based discounts or bundled service agreements to offset higher per-unit costs.

These tariff-induced cost adjustments have also influenced competitive positioning among global suppliers. Manufacturers with vertically integrated supply chains are better equipped to absorb tariff impacts, while smaller innovators have explored strategic partnerships to maintain market access. Payers are closely monitoring these developments, evaluating the net effect on overall treatment costs and reimbursement policies. The cumulative outcome is a recalibration of pricing strategies and distribution models, as stakeholders seek to preserve access to life-saving neurothrombectomy therapies without compromising financial sustainability.

Unveiling Market Segmentation Driving Competitive Insights

A nuanced examination of market segmentation reveals how specific device categories and clinical pathways drive competitive differentiation. Within the device type framework, aspiration catheters distinguish between intermediate bore designs optimized for distal vessel navigation and large bore variants engineered for rapid clot aspiration. Combined systems, which integrate aspiration and stent retriever functions, are split between turnkey integrated platforms and standalone adjunct components that allow clinicians to customize procedural workflows. Among stent retrievers, coated models are gaining traction due to enhanced biocompatibility and reduced vessel trauma compared to uncoated alternatives.

Procedure type segmentation highlights that pure aspiration thrombectomy protocols are frequently preferred in tortuous anatomies, while mechanical thrombectomy using stent retrievers remains the gold standard for large vessel occlusions. The combined approach, whether executed sequentially or simultaneously, is increasingly adopted for challenging clots that resist single-modality removal. End users span ambulatory surgical centers focusing on outpatient interventions, hospitals differentiated into comprehensive stroke centers capable of advanced imaging and interventional suites versus primary stroke centers prioritizing rapid thrombolysis, and specialized neurology centers with multidisciplinary stroke teams. Distribution channels encompass direct sales forces fostering close clinical partnerships, e-commerce solutions enabling rapid replenishment, and third party distributors segmenting further into independent operators or value-added resellers that provide training and technical support.

Regional Market Dynamics Shaping Growth Trajectories

Regional dynamics shape the trajectory of neurothrombectomy adoption through variations in healthcare infrastructure, regulatory environments, and funding models. In the Americas, particularly North America, advanced reimbursement frameworks and established stroke care networks have driven widespread uptake of both aspiration and mechanical thrombectomy techniques. Latin American markets are emerging as growth frontiers, buoyed by public-private partnerships that expand interventional capacity.

Across Europe, Middle East & Africa, harmonization within the European Union facilitates device approvals, yet reimbursement nuances at the national level create pockets of variable access. Comprehensive stroke centers in major urban centers lead adoption of next-generation combined systems, while primary stroke centers focus on maintaining streamlined pathways for mechanical thrombectomy referrals. In the Middle East, targeted investments in tertiary care facilities accelerate the integration of specialized neurology centers, and in Africa, pilot programs are testing scalable distribution models to reach underserved communities.

The Asia-Pacific region presents a diverse landscape: established markets such as Japan and Australia exhibit high procedural volumes and early adoption of large bore aspiration catheters, whereas emerging economies in Southeast Asia and India are prioritizing cost-effective standalone adjuncts. Strategic alliances between global suppliers and local distributors are critical to overcoming regulatory hurdles and ensuring after-sales support in remote facilities.

Strategic Moves of Leading Industry Players

Leading medical technology companies are pursuing differentiated strategies to capture share in the neurothrombectomy arena. Medtronic’s recent capital infusion into stent retriever development focuses on refining device deliverability and reducing procedure times. Penumbra has positioned its integrated aspiration platforms as benchmarks for thrombus removal efficacy, emphasizing clinical data that highlights superior rates of first-pass recanalization. Stryker’s acquisition-driven expansion into Asia-Pacific leverages partnerships with local distributors to navigate complex regulatory pathways and establish training programs at key stroke centers.

Johnson & Johnson has doubled down on research into novel surface coatings that minimize platelet adhesion, while Boston Scientific is optimizing its standalone adjunct solutions to meet rising demand in ambulatory surgical environments. Mid-tier innovators are collaborating with leading neurointerventionalists to pilot biocompatible polymer technologies aimed at reducing inflammation and vessel injury. Across the board, companies are enhancing their service portfolios by integrating digital platforms for procedure simulation, post-market surveillance, and outcome tracking, reinforcing long-term partnerships with reference sites and shaping the next phase of competitive differentiation.

Strategic Imperatives for Market Leadership

Industry leaders should undertake a series of decisive actions to reinforce market position and capitalize on emerging opportunities. First, investing in modular device platforms that can adapt to both aspiration and stent retriever modalities will enable quicker integration of new technologies and reduce inventory costs. Second, diversifying supply chains to include regional manufacturing hubs will mitigate tariff impacts and enhance responsiveness to local market demands. Third, fostering cross-disciplinary collaboration between neurointerventionalists and data scientists will accelerate the development of predictive analytics tools that personalize treatment strategies.

Furthermore, engaging early with payers and regulatory agencies to validate real-world evidence and outcome metrics can streamline reimbursement negotiations. Leaders should also prioritize expanding training initiatives through digital simulation and teleproctoring, ensuring that newer centers can achieve optimal procedural efficiency and safety. Finally, building robust after-sales service frameworks, including predictive maintenance for reusable components and on-demand technical support, will strengthen customer loyalty and drive long-term revenue growth.

Comprehensive Analytical Approach and Data Validation Processes

This analysis was constructed through a rigorous multi-stage research methodology combining both primary and secondary data sources. Expert interviews were conducted with leading neurointerventionalists, hospital procurement directors, and regulatory specialists to capture qualitative insights into device performance, procedural preferences, and market dynamics. Secondary research drew on peer-reviewed clinical studies, regulatory filings, patent databases, and industry publications to validate device approvals, technological milestones, and competitive developments.

Market segmentation and competitive benchmarking were performed using proprietary data models that triangulate shipment volumes, installed base figures, and financial disclosures. Regional analyses integrated health economic data, reimbursement schedules, and healthcare infrastructure indices to assess adoption rates across various markets. All quantitative inputs underwent cross-verification with third-party databases to ensure accuracy. The final report synthesizes these findings into actionable insights, supported by detailed appendices that document data sources, interview protocols, and evaluation criteria.

Summarizing Critical Insights and Future Directions

In summary, the neurothrombectomy devices market is at an inflection point where technological innovation, regulatory developments, and evolving care pathways converge to redefine stroke intervention. The rise of combined systems that integrate aspiration and stent retriever functions, along with advances in device coatings, is driving improved clinical outcomes and expanding patient eligibility. Tariff-related cost pressures have prompted strategic adjustments across the supply chain, while region-specific reimbursement frameworks continue to influence adoption rates.

Segmentation analyses underscore the importance of flexible device portfolios tailored to diverse procedural environments, from ambulatory centers to specialized neurology hubs. Regional insights highlight that growth will be driven by strategic partnerships in emerging markets and sustained investment in training and digital support services. Leading companies are differentiating through product innovation, targeted acquisitions, and enhanced service offerings. By following the actionable recommendations provided, stakeholders can navigate the complexities of this dynamic landscape and position themselves at the forefront of next-generation stroke care.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Aspiration Catheters
      • Intermediate Bore
      • Large Bore
    • Combined Systems
      • Integrated System
      • Standalone Adjunct
    • Stent Retrievers
      • Coated
      • Uncoated
  • Procedure Type
    • Aspiration Thrombectomy
    • Combined Approach
      • Sequential
      • Simultaneous
    • Mechanical Thrombectomy
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
      • Comprehensive Stroke Centers
      • Primary Stroke Centers
    • Specialized Neurology Centers
  • Distribution Channel
    • Direct Sales
    • E Commerce
    • Third Party Distributor
      • Independent Distributor
      • Value Added Distributor
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Stryker Corporation
  • Medtronic plc
  • Penumbra, Inc.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Terumo Corporation
  • Imperative Care, Inc.
  • Rapid Medical Ltd.
  • Acandis GmbH & Co. KG
  • Phenox GmbH

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neurothrombectomy Devices Market, by Device Type
8.1. Introduction
8.2. Aspiration Catheters
8.2.1. Intermediate Bore
8.2.2. Large Bore
8.3. Combined Systems
8.3.1. Integrated System
8.3.2. Standalone Adjunct
8.4. Stent Retrievers
8.4.1. Coated
8.4.2. Uncoated
9. Neurothrombectomy Devices Market, by Procedure Type
9.1. Introduction
9.2. Aspiration Thrombectomy
9.3. Combined Approach
9.3.1. Sequential
9.3.2. Simultaneous
9.4. Mechanical Thrombectomy
10. Neurothrombectomy Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.3.1. Comprehensive Stroke Centers
10.3.2. Primary Stroke Centers
10.4. Specialized Neurology Centers
11. Neurothrombectomy Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. E Commerce
11.4. Third Party Distributor
11.4.1. Independent Distributor
11.4.2. Value Added Distributor
12. Americas Neurothrombectomy Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Neurothrombectomy Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Neurothrombectomy Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Stryker Corporation
15.3.2. Medtronic plc
15.3.3. Penumbra, Inc.
15.3.4. Johnson & Johnson
15.3.5. Boston Scientific Corporation
15.3.6. Terumo Corporation
15.3.7. Imperative Care, Inc.
15.3.8. Rapid Medical Ltd.
15.3.9. Acandis GmbH & Co. KG
15.3.10. Phenox GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NEUROTHROMBECTOMY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. NEUROTHROMBECTOMY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. NEUROTHROMBECTOMY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 64. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 65. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 66. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 68. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 70. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 72. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 78. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 123. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 129. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 133. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 135. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 139. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 153. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 154. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 155. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 156. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 157. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 159. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 163. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 165. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 169. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 203. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 209. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 223. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 225. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 226. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 227. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 229. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 233. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 235. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 237. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 239. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 263. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 265. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 269. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 273. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 274. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 275. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 276. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 279. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 293. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 294. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 295. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 296. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 297. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 299. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 303. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 304. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 305. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 306. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2030 (USD MILLION)
TABLE 307. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 308. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2030 (USD MILLION)
TABLE 309. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 311. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neurothrombectomy Devices market report include:
  • Stryker Corporation
  • Medtronic plc
  • Penumbra, Inc.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Terumo Corporation
  • Imperative Care, Inc.
  • Rapid Medical Ltd.
  • Acandis GmbH & Co. KG
  • Phenox GmbH

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 992.09 Million
Forecasted Market Value ( USD ) by 2030 $ 1790 Million
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neurothrombectomy Devices Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Neurothrombectomy Devices Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares), By End Use (Hospital, Emergency Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecast, 2025 - 2030 - Product Image

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares), By End Use (Hospital, Emergency Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecast, 2025 - 2030

  • Report
  • 154 Pages
  • Global
From
Neurothrombectomy Devices - Global Strategic Business Report - Product Image

Neurothrombectomy Devices - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Neurothrombectomy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neurothrombectomy Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Neurovascular Devices Market Size, Share & Trends Analysis Report by Device (Neurothrombectomy Devices, Support Devices), Therapeutic Application (Stroke, Cerebral Artery Stenosis), Size, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Neurovascular Devices Market Size, Share & Trends Analysis Report by Device (Neurothrombectomy Devices, Support Devices), Therapeutic Application (Stroke, Cerebral Artery Stenosis), Size, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From

About the Neurothrombectomy Device Market

The Neurothrombectomy Device market is a subset of the Neurology Devices market, which includes a variety of medical devices used to diagnose and treat neurological conditions. Neurothrombectomy Devices are used to remove blood clots from the brain, which can cause stroke. These devices are typically inserted through a catheter and guided to the clot using imaging technology. The device then uses suction or mechanical force to remove the clot. The Neurothrombectomy Device market is growing due to the increasing prevalence of stroke and other neurological conditions. The market is also driven by technological advancements in imaging and clot removal technology. Some companies in the Neurothrombectomy Device market include Medtronic, Stryker, Johnson & Johnson, and Penumbra. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.